A detailed history of Ubs Asset Management Americas Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 344,904 shares of BHC stock, worth $2.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
344,904
Holding current value
$2.85 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.1 - $10.41 $2.1 Million - $3.59 Million
344,904 New
344,904 $2.4 Million
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $25.8 Million - $33.2 Million
-1,193,772 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $27.5 Million - $34.6 Million
1,193,772 New
1,193,772 $33 Million
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $2.06 Million - $3.32 Million
-96,594 Closed
0 $0
Q4 2020

Mar 01, 2021

BUY
$15.31 - $21.12 $1.48 Million - $2.04 Million
96,594 New
96,594 $2.01 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.99B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.